NBIX - Neurocrine Biosciences, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 57.83B
Enterprise Value 37.77B
Trailing P/E N/A
Forward P/E 130.74
PEG Ratio (5 yr expected) 1-3.12
Price/Sales (ttm)15.10
Price/Book (mrq)19.13
Enterprise Value/Revenue 314.98
Enterprise Value/EBITDA 685.15

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019


Profit Margin -7.56%
Operating Margin (ttm)16.67%

Management Effectiveness

Return on Assets (ttm)6.12%
Return on Equity (ttm)-10.13%

Income Statement

Revenue (ttm)518.56M
Revenue Per Share (ttm)5.72
Quarterly Revenue Growth (yoy)94.70%
Gross Profit (ttm)393.45M
Net Income Avi to Common (ttm)-39.19M
Diluted EPS (ttm)-0.43
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)524.07M
Total Cash Per Share (mrq)5.74
Total Debt (mrq)463.85M
Total Debt/Equity (mrq)113.33
Current Ratio (mrq)8.79
Book Value Per Share (mrq)4.48

Cash Flow Statement

Operating Cash Flow (ttm)27.36M
Levered Free Cash Flow (ttm)52.13M

Trading Information

Stock Price History

Beta (3Y Monthly) 1.37
52-Week Change 3-18.84%
S&P500 52-Week Change 34.42%
52 Week High 3126.98
52 Week Low 364.72
50-Day Moving Average 380.30
200-Day Moving Average 381.82

Share Statistics

Avg Vol (3 month) 3850.99k
Avg Vol (10 day) 3438.7k
Shares Outstanding 591.29M
Float 89.96M
% Held by Insiders 11.27%
% Held by Institutions 1105.09%
Shares Short (May 31, 2019) 44.61M
Short Ratio (May 31, 2019) 44.85
Short % of Float (May 31, 2019) 46.80%
Short % of Shares Outstanding (May 31, 2019) 45.06%
Shares Short (prior month Apr 30, 2019) 43.46M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4Dec 29, 1995
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A